Endotoxins - The invisible companion in biomaterials research

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 5, 2013, Pages 391-402

  Lieder, Ramona ^a,b   Petersen, Pétur Henry ^c   Sigurjónsson, Ólafur Eysteinn ^a,b,c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b REYKJAVIK UNIVERSITY   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENDOTOXINS; BIOLOGICAL EFFECTS; CLINICAL TREATMENTS; HEALTH IMPLICATIONS; IN-VITRO EVALUATION; INFLAMMATORY REACTION; ORTHOPEDIC FIXATIONS; STANDARD GUIDELINES;

BIOMEDICAL EQUIPMENT; IMPLANTS (SURGICAL); POLYMERS;

BIOLOGICAL MATERIALS;

BIOMATERIAL; CHITOSAN; ENDOTOXIN; LIPID A; LIPOPOLYSACCHARIDE; POLYETHYLENE; TITANIUM; TITANIUM DERIVATIVE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANION EXCHANGE CHROMATOGRAPHY; BIOLOGICAL ACTIVITY; BONE REGENERATION; CELL PROLIFERATION; CELL SURFACE; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEVICE REMOVAL; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTOXEMIA; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; FOREIGN BODY REACTION; GEL FILTRATION CHROMATOGRAPHY; HUMAN; IMPLANT; IN VITRO STUDY; INNATE IMMUNITY; METAL IMPLANTATION; MOLECULAR WEIGHT; MULTIPLE ORGAN FAILURE; OSTEOLYSIS; OUTCOME ASSESSMENT; PERIODONTITIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; WOUND HEALING IMPAIRMENT; ADVERSE EFFECTS; ANIMAL; BIOFOULING; CHEMICALLY INDUCED; CHEMISTRY; PATHOLOGY; PREVENTION AND CONTROL; TOOTH PROSTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOFOULING; DENTAL PROSTHESIS; ENDOTOXINS; HUMANS; PERIODONTITIS;

EID: 84883174339     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0636     Document Type: Review

References (141)

1. Goodman, S.B., Go'mez Barrena, E., Takagi, M., and Konttinen, Y.T. Biocompatibility of total joint replacements: a review. J Biomed Mater Res A 90, 603, 2009
2. Amaral, I.F., Cordeiro, A.L., Sampaio, P., and Barbosa, M.A. Attachment, spreading and short-term proliferation of human osteoblastic cells cultured on chitosan films with different degrees of acetylation. J Biomater Sci Polym Ed 18, 469, 2007
3. Gorbet, M.B., and Sefton, M.V. Endotoxin: the uninvited guest. Biomaterials 26, 6811, 2005
4. Maitz, M.F., Teichmann, J., Sperling, C., and Werner, C. Surface endotoxin contamination and hemocompatibility evaluation of materials. J Biomed Mater Res B Appl Biomater 90, 18, 2009
5. Ragab, A.A., Van De Motter, R., Lavish, S.A., Goldberg, V.M., Ninomiya, J.T., Carlin, C.R., et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 17, 803, 1999
6. Bryans, T.D., Braithwaite, C., Broad, J., Cooper, J.F., Darnell, K.R., Hitchins, V.M., et al. Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency. Biomed Instrum Technol 38, 73, 2004
7. Caroff, M., and Karibian, D. Structure of bacterial lipopolysaccharides. Carbohydr Res 338, 2431, 2003
8. Muroi, M., and Tanamoto, K. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide- induced activation of NF-kappaB through human tolllike receptor 4. Infect Immun 70, 6043, 2002
9. Raetz, C.R., and Whitfield, C. Lipopolysaccharide endotoxins. Annu Rev Biochem 71, 635, 2002
10. Darkow, R., Groth, T., Albrecht, W., Lu? tzow, K., and Paul, D. Functionalized nanoparticles for endotoxin binding in aqueous solutions. Biomaterials 20, 1277, 1999
11. Gutsmann, T., Schromm, A.B., and Brandenburg, K. The physicochemistry of endotoxins in relation to bioactivity. Int J Med Microbiol 297, 341, 2007
12. Caroff, M., Karibian, D., Cavaillon, J.M., and Haeffner- Cavaillon, N. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 4, 915, 2002
13. Joiner, K.A., Schmetz, M.A., Goldman, R.C., Leive, L., and Frank, M.M.Mechanism of bacterial resistance to complementmediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and Opolysaccharide coverage of lipid A core oligosaccharide. Infect Immun 45, 113, 1984
14. Wandrey, C., and Vidal, D.S. Purification of polymeric biomaterials. Ann N Y Acad Sci 944, 187, 2001
15. Fang, H., Wei, J., and Yu, Y. In vivo studies of endotoxin removal by lysine-cellulose adsorbents. Biomaterials 25, 5433, 2004
16. Miyake, K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin Immunol 16, 11, 2004
17. Nalepka, J.L., and Greenfield, E.M. Detection of bacterial endotoxin in human tissues. Biotechniques 37, 413, 2004
18. Glauser, M.P., Zanetti, G., Baumgartner, J.D., and Cohen, J. Septic shock: pathogenesis. Lancet 338, 732, 1991
19. Opal, S.M. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297, 365, 2007
20. Marshall, J.C., Foster, D., Vincent, J.L., Cook, D.J., Cohen, J., Dellinger, R.P., et al. Diagnostic and prognostic implicationsof endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190, 527, 2004
21. Shibayama, Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol 151, 315, 1987
22. Shibayama, Y. The role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failure. J Pathol 151, 133, 1987
23. Horn, D.L., Opal, S.M., and Lomastro, E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis. Scand J Infect Dis Suppl 101, 9, 1996
24. Wilson, M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog 78 (Pt 1), 19, 1995
25. Gagnon, F., Knoernschild, K.L., Payant, L., Tompkins, G.R., Litaker, M.S., and Schuster, G.S. Endotoxin affinity for provisional restorative resins. J Prosthodont 3, 228, 1994
26. Knoernschild, K.L., Lefebvre, C.A., Schuster, G.S., Payant, L.M., and Gagnon, F.M. Endotoxin adherence to and elution from two casting alloys. Int J Prosthodont 7, 22, 1994
27. Mombelli, A., van Oosten, M.A., Schurch, E., and Land, N.P. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 2, 145, 1987
28. Lindhe, J., Berglundh, T., Ericsson, I., Liljenberg, B., and Marinello, C. Experimental breakdown of peri-implant and periodontal tissues. A study in the beagle dog. Clin Oral Implants Res 3, 9, 1992
29. Greenfield, E.M., Bi, Y., Ragab, A.A., Goldberg, V.M., Nalepka, J.L., and Seabold, J.M. Does endotoxin contribute to aseptic loosening of orthopedic implants? J Biomed Mater Res B Appl Biomater 72, 179, 2005
30. Sundfeldt, M., Carlsson, L.V., Johansson, C.B., Thomsen, P., and Gretzer, C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 77, 177, 2006
31. Nelson, C.L., McLaren, A.C., McLaren, S.G., Johnson, J.W., and Smeltzer, M.S. Is aseptic loosening truly aseptic? Clin Orthop Relat Res 25, 2005
32. Williams, D. Endotoxins and medical devices: the significance of dead bacteria. Med Device Technol 14, 8, 2003
33. Bi, Y., Seabold, J.M., Kaar, S.G., Ragab, A.A., Goldberg, V.M., Anderson, J.M., et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16, 2082, 2001
34. Nalepka, J.L., Lee, M.J., Kraay, M.J., Marcus, R.E., Goldberg, V.M., Chen, X., et al. Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis. Clin Orthop Relat Res 451, 229, 2006
35. Engesaeter, L.B., Lie, S.A., Espehaug, B., Furnes, O., Vollset, S.E., and Havelin, L.I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74, 644, 2003
36. Taki, N., Tatro, J.M., Lowe, R., Goldberg, V.M., and Greenfield, E.M. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 40, 1276, 2007
37. Santavirta, S., Konttinen, Y.T., Bergroth, V., Eskola, A., Tallroth, K., and Lindholm, T.S. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am 72, 252, 1990
38. Lassus, J., Waris, V., Xu, J.W., Li, T.F., Hao, J., Nietosvaara, Y., et al. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 120, 328, 2000
39. Takagi, M., Tamaki, Y., Hasegawa, H., Takakubo, Y., Konttinen, L., Tiainen, V.M., et al. Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A 81, 1017, 2007
40. Tatro, J.M., Taki, N., Islam, A.S., Goldberg, V.M., Rimnac, C.M., Doerschuk, C.M., et al. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res 25, 361, 2007
41. Cho, D.R., Shanbhag, A.S., Hong, C.Y., Baran, G.R., and Goldring, S.R. The role of adsorbed endotoxin in particleinduced stimulation of cytokine release. J Orthop Res 20, 704, 2002
42. Munford, R.S. Detoxifying endotoxin: time, place and person. J Endotoxin Res 11, 69, 2005
43. Beutler, B. Inferences, questions and possibilities in Tolllike receptor signalling. Nature 430, 257, 2004
44. Udagawa, N., Sato, N., Yang, S., Nakamura, M., Yamashita, T., Nakamura, H., et al. Signal transduction of lipopolysaccharide- induced osteoclast differentiation. Periodontol 2000 43, 56, 2007
45. Hotchkiss, R.S., and Karl, I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348, 138, 2003
46. Beutler, B., and Rietschel, E.T. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3, 169, 2003
47. Hoffmann, J.A., Kafatos, F.C., Janeway, C.A., and Ezekowitz, R.A. Phylogenetic perspectives in innate immunity. Science 284, 1313, 1999
48. Levin, M., Quint, P.A., Goldstein, B., Barton, P., Bradley, J.S., Shemie, S.D., et al. Recombinant bactericidal/permeability- increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356, 961, 2000
49. Opal, S.M., Palardy, J.E., Marra, M.N., Fisher, C.J., McKelligon, B.M., and Scott, R.W. Relative concentrations of endotoxin- binding proteins in body fluids during infection. Lancet 344, 429, 1994
50. Hamann, L., Alexander, C., Stamme, C., Za? hringer, U., Schumann, R.R. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun 73, 193-200 2005
51. Corradin, S.B., Maue?l, J., Gallay, P., Heumann, D., Ulevitch, R.J., and Tobias, P.S. Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein. J Leukoc Biol 52, 363, 1992
52. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J., and Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431, 1990
53. Wang, D., Pabst, K.M., Aida, Y., and Pabst, M.J. Lipopolysaccharide- inactivating activity of neutrophils is due to lactoferrin. J Leukoc Biol 57, 865, 1995
54. Loppnow, H., Brade, H., Du? rrbaum, I., Dinarello, C.A., Kusumoto, S., Rietschel, E.T., et al. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142, 3229, 1989
55. Persing, D.H., Coler, R.N., Lacy, M.J., Johnson, D.A., Baldridge, J.R., Hershberg, R.M., et al. Taking toll: lipid Amimetics as adjuvants and immunomodulators. Trends Microbiol 10, S32-7 2002
56. Wang, X., and Quinn, P.J. Lipopolysaccharide: Biosynthetic pathway and structure modification. Prog Lipid Res 49, 97- 107 2010
57. Lynn, W.A. Anti-endotoxin therapeutic options for the treatment of sepsis. J Antimicrob Chemother 41 Suppl A, 71, 1998
58. Llewelyn, M., and Cohen, J. New insights into the pathogenesis and therapy of sepsis and septic shock. Curr Clin Top Infect Dis 21, 148, 2001
59. Raetz, C.R. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol 175, 5745, 1993
60. Rietschel, E.T., Brade, H., Holst, O., Brade, L., Mu? ller- Loennies, S., Mamat, U., et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216, 39, 1996
61. Kawaguchi, H., Hizuta, A., Tanaka, N., and Orita, K. Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol 89, 317, 1995
62. Benahmed, M., Heymann, D., Pilet, P., Bienvenu, J., and Daculsi, G. LPS increases biomaterial degradation by human monocytes in vitro. J Biomed Mater Res 34, 115, 1997
63. Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7, 292, 2007
64. Boyle, W.J., Simonet, W.S., and Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337, 2003
65. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20, 345, 1999
66. Bauer, T.W. Particles and periimplant bone resorption. Clin Orthop Relat Res 138, 2002
67. Itoh, K., Udagawa, N., Kobayashi, K., Suda, K., Li, X., Takami, M., et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 170, 3688, 2003
68. Jimi, E., Nakamura, I., Duong, L.T., Ikebe, T., Takahashi, N., Rodan, G.A., et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247, 84, 1999
69. Schwab, L.P., Xing, Z., Hasty, K.A., and Smith, R.A. Titanium particles and surface-bound LPS activate different pathways in IC-21 macrophages. J Biomed Mater Res B Appl Biomater 79, 66, 2006
70. Gruber, R. Cell biology of osteoimmunology. Wien Med Wochenschr 160, 438, 2010
71. Sato, N., Takahashi, N., Suda, K., Nakamura, M., Yamaki, M., Ninomiya, T., et al. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med 200, 601, 2004
72. Hirayama, C., and Sakata, M. Chromatographic removal of endotoxin from protein solutions by polymer particles. J Chromatogr B Analyt Technol Biomed Life Sci 781, 419, 2002
73. Gristina, A.G. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res 106, 1994
74. Bundy, K.J. Corrosion and other electrochemical aspects of biomaterials. Crit Rev Biomed Eng 22, 139, 1994
75. van Putten, S.M., Wu? bben, M., Plantinga, J.A., Hennink, W.E., van Luyn, M.J., and Harmsen, M.C. Endotoxin contamination delays the foreign body reaction. J Biomed Mater Res A 98, 527, 2011
76. Long, M., and Rack, H.J. Titanium alloys in total joint replacement - a materials science perspective. Biomaterials 19, 1621, 1998
77. Yao, J., Cs-Szabó, G., Jacobs, J.J., Kuettner, K.E., and Glant, T.T. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 79, 107, 1997
78. Vermes, C., Chandrasekaran, R., Jacobs, J.J., Galante, J.O., Roebuck, K.A., and Glant, T.T. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am 83- A, 201, 2001
79. Wang, M.L., Nesti, L.J., Tuli, R., Lazatin, J., Danielson, K.G., Sharkey, P.F., et al. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20, 1175, 2002
80. Xing, Z., Pabst, M.J., Hasty, K.A., and Smith, R.A. Accumulation of LPS by polyethylene particles decreases bone attachment to implants. J Orthop Res 24, 959, 2006
81. Bi, Y., Collier, T.O., Goldberg, V.M., Anderson, J.M., and Greenfield, E.M. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Res 20, 696, 2002
82. Nakagawa, Y., Murai, T., Hasegawa, C., Hirata, M., Tsuchiya, T., Yagami, T., et al. Endotoxin contamination in wound dressings made of natural biomaterials. J Biomed Mater Res B Appl Biomater 66, 347, 2003
83. Ashwood, P., Thompson, R.P., and Powell, J.J. Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med (Maywood) 232, 107, 2007
84. Nelson, S.K., Knoernschild, K.L., Robinson, F.G., and Schuster, G.S. Lipopolysaccharide affinity for titanium implant biomaterials. J Prosthet Dent 77, 76, 1997
85. Inada, K., Endo, S., Takahashi, K., Suzuki, M., Narita, T., Yoshida, T., et al. Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol 35, 303, 1991
86. Cooperstock, M.S., Tucker, R.P., and Baublis, J.V. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet 1, 1272, 1975
87. Orishimo, K.F., Claus, A.M., Sychterz, C.J., and Engh, C.A. Relationship between polyethylene wear and osteolysis in hips with a second-generation porous-coated cementless cup after seven years of follow-up. J Bone Joint Surg Am 85-A, 1095, 2003
88. Hallan, G., Dybvik, E., Furnes, O., and Havelin, L.I. Metalbacked acetabular components with conventional polyethylene: a review of 9113 primary components with a follow-up of 20 years. J Bone Joint Surg Br 92, 196, 2010
89. Dean, D.D., Schwartz, Z., Liu, Y., Blanchard, C.R., Agrawal, C.M., Mabrey, J.D., et al. The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J Bone Joint Surg Am 81, 452, 1999
90. Dean, D.D., Schwartz, Z., Blanchard, C.R., Liu, Y., Agrawal, C.M., Lohmann, C.H., et al. Ultrahigh molecular weight polyethylene particles have direct effects onproliferation, differentiation, and local factor production of MG63 osteoblast-like cells. J Orthop Res 17, 9, 1999
91. Skoglund, B., Larsson, L., and Aspenberg, P.A. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. J Bone Joint Surg Br 84, 767, 2002
92. Di Martino, A., Sittinger, M., and Risbud, M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26, 5983, 2005
93. Bumgardner, J.D., Wiser, R., Elder, S.H., Jouett, R., Yang, Y., and Ong, J.L. Contact angle, protein adsorption and osteoblast precursor cell attachment to chitosan coatings bonded to titanium. J Biomater Sci Polym Ed 14, 1401, 2003
94. Ermak, I.M., Davydova, V.N., Gorbach, V.I., Berdyshev, E.L., Kuznetsova, T.A., Ivanushko, I.A., et al. Modification of biological activity of lipopolysaccharide in the complex with chitosan. Bull Exp Biol Med 137, 379, 2004
95. Naberezhnykh, G.A., Gorbach, V.I., Likhatskaya, G.N., Davidova, V.N., and Solov'eva TF. Interaction of chitosans and their N-acylated derivatives with lipopolysaccharide of gram-negative bacteria. Biochemistry (Mosc) 73, 432, 2008
96. Lamb Machado, R., de Arruda, E.J., Costapinto Santana, C., and Alves Bueno, S.M. Evaluation of a chitosan membrane for removal of endotoxin from human IgG solutions. Proc Biochem 41, 2252, 2006
97. Yermak, I.M., Davidova, V.N., Gorbach, V.I., Luk'yanov PA, Solov'eva TF, Ulmer, A.J., et al. Forming and immunological properties of some lipopolysaccharide-chitosan complexes. Biochimie 88, 23, 2006
98. Davydova, V.N., Yermak, I.M., Gorbach, V.I., Krasikova, I.N., and Solov'eva TF. Interaction of bacterial endotoxins with chitosan. Effect of endotoxin structure, chitosan molecular mass, and ionic strength of the solution on the formation of the complex. Biochemistry (Mosc) 65, 1082, 2000
99. Lieder, R., Gaware, V.S., Thormodsson, F., Einarsson, J.M., Ng, C.H., Gislason, J., et al. Endotoxins affect bioactivity of chitosan derivatives in cultures of bone marrow-derived human mesenchymal stem cells. Acta Biomater 9, 4771, 2013
100. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006
101. Li, Z., and Kawashita, M. Current progress in inorganic artificial biomaterials. J Artif Organs 14, 163, 2011
102. Takemoto, Y., Nakatani, T., Sugimura, K., Yoshimura, R., and Tsuchida, K. Endotoxin adsorption of various dialysis membranes: in vitro study. Artif Organs 27, 1134, 2003
103. Suri, R.M., and Austyn, J.M. Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J Immunol Methods 214, 149, 1998
104. Kanayama, Y., Aoki, C., and Sakai, Y. Development of low endotoxin gelatin for regenerative medicine. Biol Pharm Bull 30, 237, 2007
105. Kumbar, S.G., Toti, U.S., Deng, M., James, R., Laurencin, C.T., Aravamudhan, A., et al. Novel mechanically competent polysaccharide scaffolds for bone tissue engineering. Biomed Mater 6, 065005 2011
106. Weber, C., Henne, B., Loth, F., Schoenhofen, M., and Falkenhagen, D. Development of cationically modified cellulose adsorbents for the removal of endotoxins. ASAIO J 41, M430-4 1995
107. Li, Y.M., Liao, J.L., Zhang, R., Henriksson, H., and Hjerte'n, S. Continuous beds for microchromatography: chromatofocusing and anion exchange chromatography. Anal Biochem 267, 121, 1999
108. Pringle, J.H., and Fletcher, M. Influence of substratum hydration and adsorbed macromolecules on bacterial attachment to surfaces. Appl Environ Microbiol 51, 1321, 1986
109. Dusseault, J., Tam, S.K., Me'nard, M., Polizu, S., Jourdan, G., Yahia, L., et al. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 76, 243, 2006
110. van Schilfgaarde, R., and de Vos, P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med (Berl) 77, 199-205 1999
111. Tam, S.K., Dusseault, J., Polizu, S., Me'nard, M., Hallé, J.P., and Yahia, L. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation. Biomaterials 27, 1296-305 2006
112. Breger, J.C., Lyle, D.B., Shallcross, J.C., Langone, J.J., and Wang, N.S. Defining critical inflammatory parameters for endotoxin impurity in manufactured alginate microcapsules. J Biomed Mater Res B Appl Biomater 91, 755, 2009
113. Radon, K. The two sides of the ''endotoxin coin''. Occup Environ Med 63, 73, 2006
114. Devleeschouwer, M.J., Cornil, M.F., and Dony, J. Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol 50, 1509, 1985
115. Hasiwa, M., Kullmann, K., von Aulock, S., Klein, C., and Hartung, T. An in vitro pyrogen safety test for immunestimulating components on surfaces. Biomaterials 28, 1367, 2007
116. qawniczek-Wa1czyk, A., and Gó rny, R.L. Endotoxins and b-glucans as markers of microbiological contamination - characteristics, detection, and environmental exposure. Ann Agric Environ Med 17, 193-208 2010
117. Hitchins, V.M., and Merritt, K. Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 46, 434, 1999
118. Petsch, D., and Anspach, F.B. Endotoxin removal from protein solutions. J Biotechnol 76, 97-119 2000
119. Magalha? es, P.O., Lopes, A.M., Mazzola, P.G., Rangel-Yagui, C., Penna, T.C., and Pessoa, A. Methods of endotoxin removal from biological preparations: a review. J Pharm Pharm Sci 10, 388-404 2007
120. Shibatani, T., Kakimoto, T., and Chibata, I. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase. Thromb Haemost 49, 91, 1983
121. Anspach, F.B., and Hilbeck, O. Removal of endotoxins by affinity sorbents. J Chromatogr A 711, 81, 1995
122. Karplus, T.E., Ulevitch, R.J., and Wilson, C.B. A new method for reduction of endotoxin contamination from protein solutions. J Immunol Methods 105, 211, 1987
123. Matsumae, H., Minobe, S., Kindan, K., Watanabe, T., Sato, T., and Tosa, T. Specific removal of endotoxin from protein solutions by immobilized histidine. Biotechnol Appl Biochem 12, 129, 1990
124. Oroszlan, S.I., and Mora, P.T. Dissociation and reconstitution of an endotoxin. Biochem Biophys Res Commun 12, 345, 1963
125. Weiser, M.M., and Rothfield, L. The reassociation of lipopolysaccharide, phospholipid, and transferase enzymes ofthe bacterial cell envelope. Isolation of binary and ternary complexes. J Biol Chem 243, 1320, 1968
126. Liu, C.L., Kamei, D.T., King, J.A., Wang, D.I., and Blankschtein, D. Separation of proteins and viruses using two-phase aqueous micellar systems. J Chromatogr B Biomed Sci Appl 711, 127, 1998
127. Bende, S., and Bertó k, L. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock. Circ Shock 19, 239, 1986
128. Cinquemani, C. Human pathogens, nosocomial infections, heat-sensitive textile implants, and an innovative approach to deal with them. J Ind Microbiol Biotechnol 38, 29, 2011
129. Neidhardt, E.A., Luther, M.A., and Recny, M.A. Rapid, two-step purification process for the preparation of pyrogen- free murine immunoglobulin G1 monoclonal antibodies. J Chromatogr 590, 255, 1992
130. Hou, K.C., and Zaniewski, R. Depyrogenation by endotoxin removal with positively charged depth filter cartridge. J Parenter Sci Technol 44, 204, 1990
131. Hou, K.C., and Zaniewski, R. Endotoxin removal by anionexchange polymeric matrix. Biotechnol Appl Biochem 12, 315, 1990
132. Pyo, S.H., Lee, J.H., Park, H.B., Hong, S.S., and Kim, J.H. A large-scale purification of recombinant histone H1.5 from Escherichia coli. Protein Expr Purif 23, 38, 2001
133. Sweadner, K.J., Forte, M., and Nelsen, L.L. Filtration removal of endotoxin (pyrogens) in solution in different states of aggregation. Appl Environ Microbiol 34, 382, 1977
134. Issekutz, A.C. Removal of gram-negative endotoxin from solutions by affinity chromatography. J Immunol Methods 61, 275, 1983
135. Chester, I.R., and Meadow, P.M. Heterogeneity of the lipopolysaccharide from Pseudomonas aeruginosa. Eur J Biochem 58, 273, 1975
136. Rangel-Yagui, C.O., Lam, H., Kamei, D.T., Wang, D.I., Pessoa, A., and Blankschtein, D. Glucose-6-phosphate dehydrogenase partitioning in two-phase aqueous mixed (nonionic/cationic) micellar systems. Biotechnol Bioeng 82, 445, 2003
137. Mazzola, P.G., Lam, H., Kavoosi, M., Haynes, C.A., Pessoa, A., Penna, T.C., et al. Affinity-tagged green fluorescent protein (GFP) extraction from a clarified E. coli cell lysate using a two-phase aqueous micellar system. Biotechnol Bioeng 93, 998-1004 2006
138. Aida, Y., and Pabst, M.J. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 132, 191, 1990
139. Jann, B., Reske, K., and Jann, K. Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Eur J Biochem 60, 239, 1975
140. Tsai, C.M., and Frasch, C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119, 115, 1982
141. Mendiola, L.R., Kouznetzova, B., Chermann, J.C., Sinoussi, F., Digeon, M., and Raynaud M. Purification of bacterial endotoxins by zonal centrifugation. Infect Immun 6, 27, 1972.